LATEST NEWS
Scripta Therapeutics raises $12M to find disease-modifying drugs that alter transcription factor activity
13 . 11 . 25
Scripta Therapeutics, based at The Oxford Science Park, has emerged from stealth by announcing a $12 million seed round to upend conventional approaches to drug discovery.
Scripta combines AI, imaging, and patient-derived models to create and...
Read More